在形大动脉狭窄症治疗方法的图书统计分析
Yang He1, Yue-Jiao Yang1, Zhao-Jun Wang1
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Frontiers in pharmacology
|April 4, 2025
概括
动脉狭窄 (CAVS) 缺乏有效的药物治疗方法. 图书统计分析揭示了关键的研究趋势,并确定了CAVS治疗的未来方向,重点是诊断和新药开发.
科学领域:
- 心血管医学 心血管医学
- 图书统计学 图书统计学
- 医学研究趋势 医学研究趋势
背景情况:
- 动脉狭窄 (CAVS) 是一种患有高死亡率的常见心血管疾病.
- 目前对CAVS的药理疗法在阻止或预防疾病进展方面无效.
- 对于新的治疗策略和对CAVS病变发生的更好理解有着至关重要的需要.
研究的目的:
- 对全球关于状大动脉狭窄症 (CAVS) 的研究进行文献计量和可视化分析.
- 识别关键的研究趋势,多产的贡献者和CAVS研究中的新兴热点.
- 为CAVS.提供有关当前和未来治疗可能性的见解.
主要方法:
- 利用科学网络数据库检索有关大动脉狭窄和相关治疗的出版物.
- 分析了使用VOSviewer和CiteSpace软件发布的787篇文章,截至2024年9月.
- 确定了为CAVS研究做出贡献的多产作者,国家,机构和期刊.
主要成果:
- 加拿大和美国在CAVS研究的出版量方面领先.
- 哈佛大学,拉瓦尔大学和加利福尼亚大学都是领先的机构.
- 顶级研究热点包括狭窄,化和进展,重点是治疗方法,病原和诊断.
结论:
- 虽然手术和干预治疗是标准的,但对于所有患者来说都不够.
- 未来的研究重点包括加强诊断,开发创新疗法,并发现用于CAVS的新药.
- 持续的研究对于应对CAVS管理中不断变化的挑战和未满足的需求至关重要.
更多相关视频
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
2.5K
05:47Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
3.9K
相关概念视频
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
